Enfortumab vedotin versus platinum rechallenge in post‐platinum, post‐pembrolizumab advanced urothelial carcinoma: A multicenter propensity score‐matched study. - Taguchi, Satoru; Kawai, Taketo; Ambe, Yoshiki; Kishitani, Kenjiro; Sugimoto, Kazuma; Miyakawa, Jimpei; Nakamura, Yu; Noda, Michio; Kaneko, Tomoyuki; Kamei, Jun; Obinata, Daisuke; Yamaguchi, Kenya; et al. (International Journal of Urology, 2023)